ProCE Banner Activity

Maximizing Efficacy and Minimizing Toxicity of ADCs Targeting HER2, HER3, and TROP-2: Strategies for Oncology Pharmacists

Slideset

Download these slides to learn how oncology pharmacists can optimize care for patients receiving ADCs targeting HER2, HER3, or TROP-2, from patient education to toxicity identification and management.

Released: April 04, 2024

Expiration: April 03, 2025

Share

Provided by

Provided by ProCE, LLC, in partnership with Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.

Partners

Clinical Care Options, LLC 123

ProCE Banner